So down 4%. Our patient numbers are down 95%. 1 out of 20. Out trial is a massive ask of newly diagnosed patients. We need to stop blaming COVID.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
